A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortium
作者： Weili Sun , Timothy Triche Jr , Jemily Malvar , Paul Gaynon , Richard Sposto
DOI: 10.1182/BLOOD-2017-09-803809
关键词:
摘要: TO THE EDITOR: Despite improvements in treating childhood leukemia, relapses remain the primary cause of death.[1][1][⇓][2][⇓][3]-[4][4] On relapse, leukemic cells are more resistant to chemotherapy. Thus, there is an urgent need incorporate new strategies treat leukemia.
ashpublications.org
bloodjournal.org参考文章(19)
Todd M. Cooper, Janet Franklin, Robert B. Gerbing, Todd A. Alonzo, Craig Hurwitz, Susana C. Raimondi, Betsy Hirsch, Franklin O. Smith, Prasad Mathew, Robert J. Arceci, James Feusner, Robert Iannone, Robert S. Lavey, Soheil Meshinchi, Alan Gamis, AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group. Cancer. ,vol. 118, pp. 761- 769 ,(2012) , 10.1002/CNCR.26190
Katherine B. Chiappinelli, Pamela L. Strissel, Alexis Desrichard, Huili Li, Christine Henke, Benjamin Akman, Alexander Hein, Neal S. Rote, Leslie M. Cope, Alexandra Snyder, Vladimir Makarov, Sadna Buhu, Dennis J. Slamon, Jedd D. Wolchok, Drew M. Pardoll, Matthias W. Beckmann, Cynthia A. Zahnow, Taha Merghoub, Timothy A. Chan, Stephen B. Baylin, Reiner Strick, Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses Cell. ,vol. 162, pp. 974- 986 ,(2015) , 10.1016/J.CELL.2015.07.011
Ari M. Melnick, Epigenetics in AML Best Practice & Research Clinical Haematology. ,vol. 23, pp. 463- 468 ,(2010) , 10.1016/J.BEHA.2010.09.017
K Nguyen, , M Devidas, S-C Cheng, M La, E A Raetz, W L Carroll, N J Winick, S P Hunger, P S Gaynon, M L Loh, Factors Influencing Survival After Relapse From Acute Lymphoblastic Leukemia: A Children's Oncology Group Study Leukemia. ,vol. 22, pp. 2142- 2150 ,(2008) , 10.1038/LEU.2008.251
G. J. Peters, J. Hodzic, B. Ortega, E. Giovannetti, A. D. Adema, R. Broekhuizen, G. J. Kaspers, I. Hubeek, Methylation Specific PCR to Characterize Methylation of the Promoter of Deoxycytidine Kinase Nucleosides, Nucleotides & Nucleic Acids. ,vol. 29, pp. 408- 413 ,(2010) , 10.1080/15257771003730078
Laura E. Hogan, Julia A. Meyer, Jun Yang, Jinhua Wang, Nicholas Wong, Wenjian Yang, Gregory Condos, Stephen P. Hunger, Elizabeth Raetz, Richard Saffery, Mary V. Relling, Deepa Bhojwani, Debra J. Morrison, William L. Carroll, Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies Blood. ,vol. 118, pp. 5218- 5226 ,(2011) , 10.1182/BLOOD-2011-04-345595
Lars Bullinger, Mathias Ehrich, Konstanze Döhner, Richard F. Schlenk, Hartmut Döhner, Matthew R. Nelson, Dirk van den Boom, Quantitative DNA methylation predicts survival in adult acute myeloid leukemia. Blood. ,vol. 115, pp. 636- 642 ,(2010) , 10.1182/BLOOD-2009-03-211003
Stephen B. Baylin, Peter A. Jones, A decade of exploring the cancer epigenome — biological and translational implications Nature Reviews Cancer. ,vol. 11, pp. 726- 734 ,(2011) , 10.1038/NRC3130
Teena Bhatla, Jinhua Wang, Debra J. Morrison, Elizabeth A. Raetz, Michael J. Burke, Patrick Brown, William L. Carroll, Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia. Blood. ,vol. 119, pp. 5201- 5210 ,(2012) , 10.1182/BLOOD-2012-01-401687
Xiaojing Yang, Han Han, Daniel D. De Carvalho, Fides D. Lay, Peter A. Jones, Gangning Liang, Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer Cancer Cell. ,vol. 26, pp. 577- 590 ,(2014) , 10.1016/J.CCR.2014.07.028